Direct Nucleic Acid Analysis via Enhanced Polymerase
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for nucleic acid analysis from biological samples, such as saliva or buccal swabs, are time-consuming, require toxic reagents, or need specialized enzymes, and have variable success rates due to inhibitor presence, making them less suitable for clinical applications.
Innovation Solution
A diagnostic assay method involving direct contact of samples with nucleic acid amplification reagents containing higher concentrations of DNA polymerase, primers, and probes, without prior purification, which allows for efficient amplification within a short time frame using a cap-based collection system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nucleic acid purification is performed using phenol-chloroform extraction, then DNA isolation efficiency is improved, but the process becomes time-consuming and requires toxic reagents
Solution Approach 1:
The invention extracts and removes the purification step entirely from the workflow. By using enhanced DNA polymerase that can function directly in crude lysates containing cellular debris and proteins, the method eliminates the time-consuming phenol-chloroform extraction process while maintaining amplification reliability.
Solution Approach 2:
The enhanced DNA polymerase acts as an intermediary that bridges the gap between crude sample lysates and functional amplification. This specialized enzyme can tolerate and function in the presence of inhibitors normally present in unpurified samples, allowing direct amplification without purification.
2Ease of operation
If standard DNA polymerase is used with unpurified samples, then the process is simplified, but amplification reliability decreases due to inhibitors
Solution Approach 1:
The invention changes the parameters of the DNA polymerase enzyme itself - using enhanced versions with higher processivity, processive synthesis rate, and tolerance to inhibitors. This allows the enzyme to maintain high amplification reliability even in the presence of crude sample contaminants, enabling direct amplification from unpurified lysates.
3Reliability
If specially-modified DNA polymerase resistant to inhibitors is used, then amplification from unpurified samples is improved, but the cost increases due to proprietary enzymes
Solution Approach 1:
The invention uses enhanced DNA polymerases with optimized parameters for processivity and inhibitor tolerance that achieve reliable amplification from crude samples without requiring expensive proprietary modifications. The enhanced enzymes maintain high reliability while being more cost-effective than specially-modified commercial products.
4Quantity of substance
If low DNA polymerase concentration is used, then reagent cost is reduced, but amplification speed and reliability decrease
Solution Approach 1:
The invention changes the quality parameters of the DNA polymerase - using enhanced versions with higher processive synthesis rates and processivity. This allows the use of lower enzyme concentrations while maintaining or improving amplification speed and reliability, thereby reducing reagent costs without sacrificing productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances the reliability and speed of nucleic acid amplification from diverse samples, including buccal and non-buccal sources, by using standard DNA polymerase and higher primer/probe concentrations, improving discrimination between positive and negative samples and reducing the impact of inhibitors.
Implementation Method 1
The nucleic acid amplification reagent comprises a DNA polymerase concentration of at least 1.0 U/reaction
Implementation Method 2
nucleic acid amplification reaction
Implementation Method 3
a primer at a concentration of at least 0.2 μM, and a probe at a concentration of at least 0.2 μM
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Methods and apparatus are described for nucleic acid analysis of swab samples without the need for purification.